As cancer costs rise, a focus on prevention
Cancer centers hope to cut deaths and financial burden
New breed of drugs offers hope in cancer war
Specialists, pharma firms optimistic about new targeted treatments
War on cancer also battles high costs
Billions of dollars at stake for patients, health industry
INTERACTIVES AND QUIZZES
ImClone's Erbitux, which has shown a survival benefit for head and neck cancer patients, stole the show at the American Society of Clinical Oncology meeting in New Orleans this week, CNBC's Mike Huckman reports.
SPECIAL REPORT: CANCER TREATMENTS
Are we winning the war on cancer?
The best medicine has to offer still isn't enough to help all cancer patients. But armed with new knowledge, doctors predict they'll be saving many more lives in the next few decades.